Trade Assertio Holdings, Inc. - ASRT CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
| Spread | 0.0486 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.024874% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.002651% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Key Stats
| Prev. Close* | 6.3906 |
| Open* | 6.4404 |
| 1-Year Change* | 136.78% |
| Day's Range* | 6.2809 - 6.4504 |
| 52 wk Range | 1.86-7.00 |
| Average Volume (10 days) | 1.48M |
| Average Volume (3 months) | 39.46M |
| Market Cap | 356.26M |
| P/E Ratio | 3.66 |
| Shares Outstanding | 55.58M |
| Revenue | 156.23M |
| EPS | 1.75 |
| Dividend (Yield %) | N/A |
| Beta | 1.40 |
| Next Earnings Date | May 8, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2023 | 6.3507 | -0.0798 | -1.24% | 6.4305 | 6.4903 | 6.2610 |
| Mar 30, 2023 | 6.3906 | 0.0898 | 1.43% | 6.3008 | 6.4504 | 6.3008 |
| Mar 29, 2023 | 6.2710 | -0.1096 | -1.72% | 6.3806 | 6.4006 | 6.1314 |
| Mar 28, 2023 | 6.2411 | 0.2892 | 4.86% | 5.9519 | 6.3408 | 5.9519 |
| Mar 27, 2023 | 5.9619 | -0.0199 | -0.33% | 5.9818 | 6.1015 | 5.8921 |
| Mar 24, 2023 | 5.8423 | 0.2493 | 4.46% | 5.5930 | 5.9519 | 5.5830 |
| Mar 23, 2023 | 5.7625 | -0.1097 | -1.87% | 5.8722 | 6.0317 | 5.7326 |
| Mar 22, 2023 | 5.7824 | -0.1595 | -2.68% | 5.9419 | 6.0915 | 5.7824 |
| Mar 21, 2023 | 5.9120 | 0.1097 | 1.89% | 5.8023 | 6.0217 | 5.8023 |
| Mar 20, 2023 | 5.7525 | -0.0299 | -0.52% | 5.7824 | 5.9320 | 5.7126 |
| Mar 17, 2023 | 5.8024 | -0.3589 | -5.83% | 6.1613 | 6.1613 | 5.8024 |
| Mar 16, 2023 | 6.2211 | 0.5783 | 10.25% | 5.6428 | 6.2909 | 5.5531 |
| Mar 15, 2023 | 5.6528 | -0.0697 | -1.22% | 5.7225 | 5.8423 | 5.5731 |
| Mar 14, 2023 | 5.8921 | 0.5484 | 10.26% | 5.3437 | 6.0516 | 5.3437 |
| Mar 13, 2023 | 5.2241 | -0.3090 | -5.58% | 5.5331 | 5.5830 | 5.2141 |
| Mar 10, 2023 | 5.7226 | -0.7676 | -11.83% | 6.4902 | 6.5402 | 5.6129 |
| Mar 9, 2023 | 6.6399 | 0.6781 | 11.37% | 5.9618 | 6.9689 | 5.9418 |
| Mar 8, 2023 | 5.9320 | -0.1794 | -2.94% | 6.1114 | 6.1414 | 5.7924 |
| Mar 7, 2023 | 6.1414 | 0.1098 | 1.82% | 6.0316 | 6.2510 | 5.9020 |
| Mar 6, 2023 | 6.0815 | -0.3589 | -5.57% | 6.4404 | 6.4504 | 6.0018 |
Assertio Holdings, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 156.234 | 111.014 | 106.275 | 229.504 | 311.77 |
| Revenue | 156.234 | 111.014 | 106.275 | 229.504 | 311.77 |
| Cost of Revenue, Total | 17.948 | 15.232 | 15.772 | 9.505 | 18.476 |
| Gross Profit | 138.286 | 95.782 | 90.503 | 219.999 | 293.294 |
| Total Operating Expense | 116.829 | 101.59 | 132.637 | 397.547 | 206.111 |
| Selling/General/Admin. Expenses, Total | 45.986 | 56.555 | 105.323 | 108.866 | 119.218 |
| Research & Development | 0 | 4.213 | 10.106 | 8.042 | |
| Depreciation / Amortization | 33.408 | 28.114 | 24.783 | 101.774 | 101.774 |
| Unusual Expense (Income) | 0.8 | 1.689 | -17.454 | 167.296 | -41.399 |
| Operating Income | 39.405 | 9.424 | -26.362 | -168.043 | 105.659 |
| Interest Income (Expense), Net Non-Operating | -7.961 | -10.22 | -15.926 | -58.389 | -68.881 |
| Other, Net | -0.278 | 0.243 | -3.225 | 3.948 | 1.197 |
| Net Income Before Taxes | 31.166 | -0.553 | -45.513 | -222.484 | 37.975 |
| Net Income After Taxes | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
| Net Income Before Extra. Items | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
| Net Income | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
| Income Available to Common Excl. Extra. Items | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
| Income Available to Common Incl. Extra. Items | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
| Dilution Adjustment | |||||
| Diluted Net Income | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
| Diluted Weighted Average Shares | 54.669 | 43.169 | 26.2087 | 17.679 | 16.052 |
| Diluted EPS Excluding Extraordinary Items | 2.00525 | -0.02967 | -1.07384 | -12.2858 | 2.29928 |
| Diluted Normalized EPS | 2.01476 | -0.00424 | -1.50671 | -6.13488 | 0.62289 |
| Total Extraordinary Items | |||||
| Interest Expense (Income) - Net Operating | 18.687 |
| Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Total revenue | 50.35 | 34.212 | 35.131 | 36.538 | 33.328 |
| Revenue | 50.35 | 34.212 | 35.131 | 36.538 | 33.328 |
| Cost of Revenue, Total | 5.914 | 4.009 | 4.228 | 3.795 | 4.896 |
| Gross Profit | 44.436 | 30.203 | 30.903 | 32.743 | 28.432 |
| Total Operating Expense | 39.728 | 27.778 | 24.34 | 24.979 | 25.347 |
| Selling/General/Admin. Expenses, Total | 13.502 | 11.7 | 10.343 | 10.438 | 13.276 |
| Research & Development | 0 | ||||
| Depreciation / Amortization | 8.37 | 8.169 | 8.169 | 8.701 | 7.175 |
| Unusual Expense (Income) | 0.1 | 0 | 0.3 | 0.4 | 0 |
| Operating Income | 10.622 | 6.434 | 10.791 | 11.559 | 7.981 |
| Interest Income (Expense), Net Non-Operating | -1.313 | -2.052 | -2.269 | -2.327 | -2.437 |
| Other, Net | -0.731 | 0.002 | -0.095 | 0.545 | -0.504 |
| Net Income Before Taxes | 8.578 | 4.384 | 8.427 | 9.777 | 5.04 |
| Net Income After Taxes | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
| Net Income Before Extra. Items | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
| Net Income | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
| Income Available to Common Excl. Extra. Items | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
| Income Available to Common Incl. Extra. Items | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
| Diluted Net Income | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
| Diluted Weighted Average Shares | 67.266 | 57.386 | 47.579 | 46.127 | 45.026 |
| Diluted EPS Excluding Extraordinary Items | 1.31646 | 0.07274 | 0.16465 | 0.1965 | 0.1023 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
| Diluted Normalized EPS | 1.31743 | 0.07274 | 0.17051 | 0.20454 | 0.1023 |
| Interest Expense (Income) - Net Operating | 11.842 | 3.9 | 1.3 | 1.645 |
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total Current Assets | 103.498 | 94.254 | 103.951 | 208.107 | 230.851 |
| Cash and Short Term Investments | 36.81 | 20.786 | 42.107 | 110.949 | 128.089 |
| Cash & Equivalents | 36.81 | 20.786 | 42.107 | 110.949 | 126.884 |
| Short Term Investments | 0 | 1.205 | |||
| Total Receivables, Net | 44.361 | 44.35 | 43.544 | 37.211 | 72.482 |
| Accounts Receivable - Trade, Net | 44.361 | 44.35 | 43.257 | 37.211 | 72.482 |
| Total Inventory | 7.489 | 11.712 | 3.412 | 3.396 | 13.042 |
| Prepaid Expenses | 14.838 | 17.406 | 14.888 | 56.551 | 17.238 |
| Total Assets | 326.547 | 303.274 | 527.17 | 932.866 | 1038.62 |
| Property/Plant/Equipment, Total - Net | 2.262 | 4.784 | 6.273 | 13.064 | 13.024 |
| Property/Plant/Equipment, Total - Gross | 14.011 | 15.57 | 18.143 | 23.837 | 26.945 |
| Accumulated Depreciation, Total | -11.749 | -10.786 | -11.87 | -10.773 | -13.921 |
| Intangibles, Net | 216.054 | 200.082 | 400.535 | 692.099 | 793.873 |
| Other Long Term Assets, Total | 3.154 | 2.575 | 2.247 | 7.812 | 0.869 |
| Total Current Liabilities | 135.019 | 132.686 | 184.553 | 246.036 | 310.58 |
| Accounts Payable | 6.685 | 14.808 | 16.193 | 6.138 | 14.732 |
| Accrued Expenses | 69.339 | 99.161 | 88.36 | 118.765 | 209.544 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 46.821 | 6.775 | 1.133 | 3.804 | |
| Total Liabilities | 224.133 | 247.76 | 469.212 | 712.531 | 869.109 |
| Total Long Term Debt | 61.319 | 72.16 | 271.258 | 446.107 | 544.23 |
| Long Term Debt | 61.319 | 72.16 | 271.258 | 446.107 | 544.23 |
| Other Liabilities, Total | 27.795 | 42.914 | 13.401 | 20.388 | 14.299 |
| Total Equity | 102.414 | 55.514 | 57.958 | 220.335 | 169.508 |
| Preferred Stock - Non Redeemable, Net | |||||
| Common Stock | 0.004 | 0.013 | 0.008 | 0.006 | 0.006 |
| Additional Paid-In Capital | 531.636 | 483.446 | 457.751 | 402.934 | 389.015 |
| Retained Earnings (Accumulated Deficit) | -429.226 | -427.945 | -399.801 | -182.6 | -219.508 |
| Other Equity, Total | 0 | -0.005 | -0.005 | ||
| Total Liabilities & Shareholders’ Equity | 326.547 | 303.274 | 527.17 | 932.866 | 1038.62 |
| Total Common Shares Outstanding | 44.6404 | 28.3922 | 20.222 | 16.0463 | 15.8501 |
| Long Term Investments | 1.579 | 1.579 | 13.064 | 11.784 | 0 |
| Current Port. of LT Debt/Capital Leases | 12.174 | 11.942 | 80 | 120 | 82.5 |
| Note Receivable - Long Term | 1.1 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total Current Assets | 125.115 | 103.498 | 112.545 | 119.348 | 124.069 |
| Cash and Short Term Investments | 61.389 | 36.81 | 58.726 | 54.428 | 61.033 |
| Cash & Equivalents | 61.389 | 36.81 | 58.726 | 54.428 | 61.033 |
| Total Receivables, Net | 48.923 | 44.361 | 36.145 | 45.468 | 39.241 |
| Accounts Receivable - Trade, Net | 48.923 | 44.361 | 36.145 | 45.368 | 38.915 |
| Total Inventory | 9.48 | 7.489 | 5.481 | 6.617 | 8.93 |
| Prepaid Expenses | 5.323 | 14.838 | 12.193 | 12.835 | 14.865 |
| Total Assets | 339.135 | 326.547 | 299.305 | 312.016 | 325.424 |
| Property/Plant/Equipment, Total - Net | 1.915 | 2.262 | 2.59 | 2.969 | 2.172 |
| Property/Plant/Equipment, Total - Gross | 13.126 | 14.011 | 14.134 | 14.277 | 13.222 |
| Accumulated Depreciation, Total | -11.211 | -11.749 | -11.544 | -11.308 | -11.05 |
| Intangibles, Net | 207.554 | 216.054 | 179.143 | 186.318 | 193.536 |
| Other Long Term Assets, Total | 2.972 | 3.154 | 3.448 | 1.802 | 5.647 |
| Total Current Liabilities | 138.527 | 135.019 | 100.48 | 116.914 | 109.09 |
| Accounts Payable | 8.523 | 6.685 | 7.666 | 16.483 | 10.609 |
| Accrued Expenses | 72.175 | 69.339 | 64.057 | 72.058 | 76.743 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 12.271 | 12.174 | 12.257 | 12.222 | 12.338 |
| Other Current Liabilities, Total | 45.558 | 46.821 | 16.5 | 16.151 | 9.4 |
| Total Liabilities | 227.273 | 224.133 | 202.445 | 219.751 | 220.121 |
| Total Long Term Debt | 61.25 | 61.319 | 66.41 | 66.751 | 71.834 |
| Long Term Debt | 61.25 | 61.319 | 66.41 | 66.751 | 71.834 |
| Other Liabilities, Total | 27.496 | 27.795 | 35.555 | 36.086 | 39.197 |
| Total Equity | 111.862 | 102.414 | 96.86 | 92.265 | 105.303 |
| Common Stock | 0.004 | 0.004 | 0.004 | 0.004 | 0.018 |
| Additional Paid-In Capital | 532.02 | 531.636 | 530.689 | 529.831 | 528.686 |
| Retained Earnings (Accumulated Deficit) | -420.162 | -429.226 | -433.833 | -437.57 | -423.401 |
| Total Liabilities & Shareholders’ Equity | 339.135 | 326.547 | 299.305 | 312.016 | 325.424 |
| Total Common Shares Outstanding | 45.3354 | 44.6404 | 44.6225 | 44.494 | 43.4359 |
| Long Term Investments | 1.579 | 1.579 | 1.579 | 1.579 |
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -1.281 | -28.144 | -217.201 | 36.908 | -102.496 |
| Cash From Operating Activities | 5.523 | -65.572 | 90.475 | 72.497 | 62.167 |
| Cash From Operating Activities | 29.077 | 26.431 | 102.946 | 106.426 | 105.502 |
| Deferred Taxes | 0 | 0 | |||
| Non-Cash Items | 9.02 | -19.647 | 205.336 | 36.361 | 40.823 |
| Cash Taxes Paid | 0 | 1.136 | 4.401 | 6.472 | 0.121 |
| Cash Interest Paid | 10.124 | 17.598 | 37.788 | 48.44 | 55.542 |
| Changes in Working Capital | -31.293 | -44.212 | -0.606 | -107.198 | 18.338 |
| Cash From Investing Activities | -18.525 | 512.801 | -1.481 | -7.082 | 57.894 |
| Capital Expenditures | -0.053 | -0.01 | -1.481 | -5.507 | -0.666 |
| Other Investing Cash Flow Items, Total | -18.472 | 512.811 | 0 | -1.575 | 58.56 |
| Cash From Financing Activities | 29.026 | -468.55 | -157.836 | -81.35 | -110.886 |
| Financing Cash Flow Items | -6.193 | -4.382 | -8.087 | -0.87 | -9.826 |
| Issuance (Retirement) of Stock, Net | 45.054 | 0.088 | 0.251 | 2.02 | 8.94 |
| Issuance (Retirement) of Debt, Net | -9.835 | -464.256 | -150 | -82.5 | -110 |
| Net Change in Cash | 16.024 | -21.321 | -68.842 | -15.935 | 9.175 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 9.064 | -1.281 | -5.887 | -9.625 | 4.544 |
| Cash From Operating Activities | 27.426 | 5.523 | 1.392 | -3.262 | -4.226 |
| Cash From Operating Activities | 8.699 | 29.077 | 21.698 | 14.286 | 6.812 |
| Non-Cash Items | 2.686 | 9.02 | 4.571 | 3.589 | 0.4 |
| Cash Taxes Paid | -8.36 | 0 | 0 | 0 | 0 |
| Cash Interest Paid | 0 | 10.124 | 5.216 | 5.216 | 0 |
| Changes in Working Capital | 6.977 | -31.293 | -18.99 | -11.512 | -15.982 |
| Cash From Investing Activities | -0.404 | -18.525 | 0 | 0 | 0 |
| Capital Expenditures | -0.053 | 0 | 0 | 0 | |
| Cash From Financing Activities | -2.443 | 29.026 | 36.548 | 36.904 | 44.473 |
| Financing Cash Flow Items | -2.443 | -6.193 | -3.421 | -3.4 | -0.388 |
| Issuance (Retirement) of Stock, Net | 0 | 45.054 | 45.054 | 45.054 | 44.861 |
| Issuance (Retirement) of Debt, Net | -9.835 | -5.085 | -4.75 | 0 | |
| Net Change in Cash | 24.579 | 16.024 | 37.94 | 33.642 | 40.247 |
| Other Investing Cash Flow Items, Total | -0.404 | -18.472 | 0 | 0 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.9481 | 2194270 | 82994 | 2022-12-31 | LOW |
| Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 2.0623 | 1146213 | -430209 | 2022-12-31 | MED |
| Bridgeway Capital Management, LLC | Investment Advisor | 1.7017 | 945800 | 150000 | 2022-12-31 | LOW |
| Littlejohn & Co. LLC | Private Equity | 1.7015 | 945677 | 0 | 2022-12-31 | LOW |
| Millennium Management LLC | Hedge Fund | 1.6923 | 940574 | -108092 | 2022-12-31 | HIGH |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.6616 | 923478 | 40771 | 2022-12-31 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 1.5664 | 870598 | 579484 | 2022-12-31 | HIGH |
| Renaissance Technologies LLC | Hedge Fund | 1.4893 | 827735 | 121200 | 2022-12-31 | HIGH |
| Friess Associates LLC | Investment Advisor | 1.3794 | 766650 | -429802 | 2022-06-30 | |
| First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 1.238 | 688075 | 188076 | 2022-12-31 | LOW |
| Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.2029 | 668534 | -205846 | 2022-12-31 | HIGH |
| D. E. Shaw & Co., L.P. | Hedge Fund | 0.9001 | 500252 | 21076 | 2022-12-31 | MED |
| American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.8065 | 448219 | 179565 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7642 | 424731 | 8124 | 2022-12-31 | LOW |
| Tekla Capital Management LLC | Investment Advisor | 0.7387 | 410575 | 0 | 2022-12-31 | LOW |
| Perritt Capital Management, Inc. | Investment Advisor | 0.7313 | 406434 | 34334 | 2022-12-31 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.6667 | 370538 | -4283 | 2022-12-31 | LOW |
| Peisert (Daniel A) | Individual Investor | 0.562 | 312364 | 153962 | 2023-02-11 | MED |
| Citadel Advisors LLC | Hedge Fund | 0.5101 | 283507 | 907 | 2022-12-31 | HIGH |
| Morgan Stanley & Co. LLC | Research Firm | 0.5076 | 282092 | -33340 | 2022-12-31 | MED |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Assertio Holdings, Inc. Company profile
Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. The company''s pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, an NSAID for relief of mild to moderate acute pain; and SPRIX, an NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.| Industry: | Pharmaceuticals (NEC) |
100 S. Saunders Road
Suite 300
60045
Income Statement
- Annual
- Quarterly
News
PRECIOUS-Fed slowdown bets steer gold toward second quarterly rise
Gold prices slipped on Friday, but the safe-haven metal was bound for its second straight quarterly rise after recent banking turmoil raised hopes of a less-aggressive U.S. Federal Reserve and shored up interest in bullion.
09:37, 31 March 2023
Singapore's DBS has seen inflows in SVB aftermath, CEO says
DBS Group, Singapore's largest bank, has benefited from inflows amounting to a "few hundred millions" in the aftermath of the collapse of Silicon Valley Bank, its chief executive said on Friday.
09:24, 31 March 2023
US STOCKS-Futures muted as investors await key inflation data
U.S. stock index futures were flat on Friday as investors steered clear of big bets ahead of crucial inflation data, amid receding fears of a banking crisis.
09:16, 31 March 2023
Asia M&As drop to decade low as tumultuous backdrop deters dealmaking
Mergers and acquisitions (M&A) in the Asia-Pacific region fell to a decade low in the first three months of this year as a tumultuous geopolitical and macroeconomic environment left dealmakers cautious.
09:14, 31 March 2023
Coal India surpasses annual output target for first time in 17 years
Coal India Ltd said on Friday it had breached its annual production target of 700 million tonnes, the first time it had surpassed its goal since the fiscal year that ended in March 2006.
09:13, 31 March 2023
Global IPOs marred by banks and recession enjoy few bright spots
A banking crisis and worries of a recession have dampened the outlook for initial public offerings (IPOs) this year, prompting companies to slow down their plans to go public in what is likely to result in lower fees for investment banks.
09:06, 31 March 2023
UniCredit shareholders gather to vote on CEO's new pay scheme
Shareholders in UniCredit met on Friday to vote on a new pay scheme for Chief Executive Andrea Orcel designed to reward outperformance with a 30% pay raise.
09:04, 31 March 2023People also watch
Still looking for a broker you can trust?
Join the 500.000+ traders worldwide that chose to trade with Capital.com